ImmuCell Corp
NASDAQ:ICCC

  • LAST PRICE
    3.7100
  • TODAY'S CHANGE (%)
    0.0500 (1.3661%)
  • Bid / Lots
    3.6500/ 3
  • Ask / Lots
    3.7500/ 10
  • Open / Previous Close
    3.7000 / 3.6600
  • Day Range
    3.7000
    3.7100
  • 52 Week Range
    3.3400
    5.5900
  • Volume
    625

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

  • Nov 13, 2024

      Show headlines and story abstract

    • 4:05PM ET on Wednesday Nov 13, 2024 by Dow Jones
      Companies Mentioned: ICCC
      sold 4,428 4,130 13,633 9,764 ------ ------- ------- ------- Gross margin 1,584 1,267 5,109 2,612 Product development expenses 786 1,118 3,079 3,328 Sales, marketing and administrative expenses 1,374 1,333 4,292 4,028 ------ ------- ------- ------- Operating expenses 2,160 2,451 7,371 7,356 NET OPERATING LOSS (576) (1,184) (2,262) (4,744) Other expenses (income), net 124 (244) 405 (113) ------ ------- ------- ------- LOSS BEFORE INCOME TAXES (700) (940) (2,667) (4,631) Income tax expense 2 - 4 4 ------ ------- ------- ------- NET LOSS ($702) ($940) ($2,671) ($4,635) ====== ======= ======= ======= Basic weighted average common shares outstanding 8,164 7,747 7,908 7,747 Basic net loss per share ($0.09) ($0.12) ($0.34) ($0.60) Diluted weighted average common shares outstanding 8,164 7,747 7,908 7,747 Diluted net loss per share ($0.09) ($0.12) ($0.34) ($0.60) Selected Balance Sheet Data (In thousands) (Unaudited) As of As of September 30, 2024 December 31, 2023 ------------------- ------------------ Cash and cash equivalents $3,809 $979 Net working capital 9,422 7,272 Total assets 44,449 43,808 Stockholders' equity $26,412 $24,993

    • 4:05PM ET on Wednesday Nov 13, 2024 by Dow Jones
      Companies Mentioned: ICCC
      sold 4,428 4,130 13,633 9,764 ------ ------- ------- ------- Gross margin 1,584 1,267 5,109 2,612 Product development expenses 786 1,118 3,079 3,328 Sales, marketing and administrative expenses 1,374 1,333 4,292 4,028 ------ ------- ------- ------- Operating expenses 2,160 2,451 7,371 7,356 NET OPERATING LOSS (576) (1,184) (2,262) (4,744) Other expenses (income), net 124 (244) 405 (113) ------ ------- ------- ------- LOSS BEFORE INCOME TAXES (700) (940) (2,667) (4,631) Income tax expense 2 - 4 4 ------ ------- ------- ------- NET LOSS ($702) ($940) ($2,671) ($4,635) ====== ======= ======= ======= Basic weighted average common shares outstanding 8,164 7,747 7,908 7,747 Basic net loss per share ($0.09) ($0.12) ($0.34) ($0.60) Diluted weighted average common shares outstanding 8,164 7,747 7,908 7,747 Diluted net loss per share ($0.09) ($0.12) ($0.34) ($0.60) Selected Balance Sheet Data (In thousands) (Unaudited) As of As of September 30, 2024 December 31, 2023 ------------------- ------------------ Cash and cash equivalents $3,809 $979 Net working capital 9,422 7,272 Total assets 44,449 43,808 Stockholders' equity $26,412 $24,993

  • Nov 7, 2024

Peers Headlines